Picture of Consun Pharmaceutical logo

1681 — Consun Pharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Consun Pharmaceutical Group FY Profit Attributable RMB910.5 Million

March 26 (Reuters) - Consun Pharmaceutical Group Ltd 1681.HK:

FY GROSS MARGIN 75.6%

FY REVENUE RMB 2,970 MILLION

FINAL DIVIDEND OF HKD0.3 PER SHARE

FY PROFIT ATTRIBUTABLE RMB910.5 MILLION

Further company coverage: 1681.HK

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Consun Pharmaceutical

See all news